Posterior Reversible Ensefalopati Sendromu (PRES): Klinik, Patofizyoloji, Görüntüleme ve Yönetimde Güncel Perspektif

Zelaya JE, Al-Khoury L. Posterior Reversible Encephalopathy Syndrome. 2026 Jan 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 32119379.

Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017 Aug;264(8):1608-1616. doi: 10.1007/s00415-016-8377-8. Epub 2017 Jan 4. PMID: 28054130; PMCID: PMC5533845. DOI: 10.1007/s00415-016-8377-8

Hobson EV, Craven I, Blank SC. Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness. Perit Dial Int. 2012 Nov-Dec;32(6):590-4. doi: 10.3747/pdi.2012.00152. PMID: 23212858; PMCID: PMC3524908..DOI: 10.3747/pdi.2012.00152

Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Feb 22;334(8):494-500. doi: 10.1056/NEJM199602223340803. PMID: 8559202. DOI: 10.1056/NEJM199602223340803

Ito Y, Arahata Y, Goto Y, Hirayama M, Nagamutsu M, Yasuda T, Yanagi T, Sobue G. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol. 1998 Mar;19(3):415-7. PMID: 9541291; PMCID: PMC8338246.

Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med. 2006 Mar 2;354(9):980-2; discussion 980-2. PMID: 16514715.

Allen JA, Adlakha A, Bergethon PR. Reversible posterior leukoencephalopathy syndrome after bevacizumab/FOLFIRI regimen for metastatic colon cancer. Arch Neurol. 2006 Oct;63(10):1475-8. doi: 10.1001/archneur.63.10.1475. PMID: 17030665.

Negro A, De Berti G, Maggi M, Santi R, Grasselli C, Rossi E. Hypertension-induced posterior reversible encephalopathy syndrome as the presentation of progressive bilateral renal artery stenosis. J Cardiol Cases. 2011 Oct 4;4(3):e168-e171. doi: 10.1016/j.jccase.2011.08.008. PMID: 30532887; PMCID: PMC6265415. DOI: 10.1016/j.jccase.2011.08.008

Zou LP, Liu LY, Li H, Wang YY, Liu Y, Chen J, Hu LY, Liu MJ, Zhang MN, Lu Q, Ma SF. Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale. BMC Neurol. 2019 Feb 21;19(1):30. doi: 10.1186/s12883-019-1247-0. PMID: 30791893; PMCID: PMC6385440

Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010 May;85(5):427-32. doi: 10.4065/mcp.2009.0590. PMID: 20435835; PMCID: PMC2861971.

Geocadin RG. Posterior Reversible Encephalopathy Syndrome. N Engl J Med. 2023 Jun 8;388(23):2171-2178. doi: 10.1056/NEJMra2114482. PMID: 37285527.

Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015 Sep;14(9):914-925. doi: 10.1016/S1474-4422(15)00111-8. Epub 2015 Jul 13. Erratum in: Lancet Neurol. 2015 Sep;14(9):874. doi: 10.1016/S1474-4422(15)00195-7. PMID: 26184985.

Largeau B, Bergeron S, Auger F, Salmon Gandonnière C, Jonville-Béra AP, Ehrmann S, Gautier S, Bordet R. Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets. Stroke. 2024 Feb;55(2):484-493. doi: 10.1161/STROKEAHA.123.044533. Epub 2023 Dec 21. PMID: 38126184.

Nesheiwat O, Lui F, Al-Khoury L. Reversible Cerebral Vasoconstriction Syndromes. 2024 Jun 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 31869187.